Harnessing a Virus to Fight Brain Cancer: $2.5 Million NIH Award Advances Experimental Glioblastoma Therapy
At Rosalind Franklin University's Helix 51 biomedical incubator, an experimental Zika virus-based therapy for glioblastoma is moving closer to potential human clinical trials. NORTH CHICAGO, Ill., Oct. 19, 2026 /PRNewswire/ -- A virus known for causing serious neurological complications...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.